Knoll Capital Management, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $148 Million distributed in 35 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Applied Therapeutics Inc. with a value of $26M, Biohaven Pharmaceutical Holding CO Ltd. with a value of $24.7M, Aldeyra Therapeutics, Inc. with a value of $18.1M, Avadel Pharmaceuticals PLC with a value of $8.44M, and Altimmune, Inc. with a value of $7.46M.

Examining the 13F form we can see an decrease of $12.2M in the current position value, from $160M to 148M.

Knoll Capital Management, LLC is based out at Miami, FL

Below you can find more details about Knoll Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $148 Million
Healthcare: $102 Million
Basic Materials: $29.8 Million
ETFs: $10.6 Million
Industrials: $2.94 Million
Consumer Defensive: $1.86 Million
Financial Services: $1.27 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 35
  • Current Value $148 Million
  • Prior Value $160 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.